[Treatment of paralytic ileus using alpha and beta-lytics].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy*; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy*; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use; D010096:Oxprenolol / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D009388:Neostigmine; D010096:Oxprenolol; D010646:Phentolamine
Trattamento dell'ileo paralitico con alfa e beta-litici